The present disclosure relates generally to formulations of anti-inflammatory5 therapeutic proteins. More specifically, the disclosure is directed to an oralformulation of anti-inflammatory proteins stabilized by lactitol and mannitol.Further, the disclosure also provides a method of preparing the oral formulation.
Inventors
Varsha Singh
